These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5237386)

  • 21. [Experience of use of bruneomycin in leukemia].
    Krasovskiĭ II; Kudinov VG
    Antibiotiki; 1969 Jan; 14(1):77-81. PubMed ID: 5253409
    [No Abstract]   [Full Text] [Related]  

  • 22. [Unfavorable result of treatment in a case of erythroleukemia with a new cytostatic antibiotic-rubidomycin].
    Polubiec A; Kolakowska-Polubiec K
    Pol Tyg Lek; 1968 Sep; 23(40):1528-9. PubMed ID: 5248190
    [No Abstract]   [Full Text] [Related]  

  • 23. Daunorubicin (NSC 82151) in the treatment of advanced childhood lymphoblastic leukemia.
    Jones B; Holland JF; Morrison AR; Lee SL; Sinks LF; Cuttner J; Rausen A; Kung F; Pluss HJ; Haurani FI; Patterson RB; Blom J; Burgert EO; Moon JH; Chevalier L; Sawitsky A; Albala MM; Forcier RJ; Falkson G; Glidewell O
    Cancer Res; 1971 Feb; 31(2):84-90. PubMed ID: 5278102
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute myeloblastic leukemia in adults.
    Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
    J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
    [No Abstract]   [Full Text] [Related]  

  • 25. Rubidomycin in acute leukaemia in adults.
    Malpas JS; Scott RB
    Br Med J; 1968 Jul; 3(5612):227-9. PubMed ID: 5243015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of 4'epi-adriamycin for advanced hypernephroma.
    Benedetto P; Ahmed T; Needles B; Watson RC; Yagoda A
    Am J Clin Oncol; 1983 Oct; 6(5):553-4. PubMed ID: 6577784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinogen survival with 75-seleniomethionine in acute myeloblastic leukemia during polychemotherapy.
    Barbui T; Battista R; Dini E
    Haematologica; 1976 Mar; 61(1):73-80. PubMed ID: 820599
    [No Abstract]   [Full Text] [Related]  

  • 28. [The chemotherapy of acute promyelocytic leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)].
    Nagao T; Kamimura O; Fuchimoto T; Chen H; Toki H
    Rinsho Ketsueki; 1974 Sep; 15(9):1021-7. PubMed ID: 4530880
    [No Abstract]   [Full Text] [Related]  

  • 29. Daunorubicin and adriamycin in the treatment of leukemia.
    Klener P; Donner L; Kozená J
    Neoplasma; 1973; 20(1):87-96. PubMed ID: 4573873
    [No Abstract]   [Full Text] [Related]  

  • 30. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
    Takemoto Y; Sampi K; Kuraishi Y; Toki H; Tamura K; Ogawa M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idarubicin oral: new formulation. No proven benefit over 60.
    Prescrire Int; 2000 Aug; 9(48):103-5. PubMed ID: 11067717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mylotarg approved for patients with CD33+ acute myeloid leukemia.
    Sorokin P
    Clin J Oncol Nurs; 2000; 4(6):279-80. PubMed ID: 11899326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multi-institutional randomized controlled clinical trial on China made 4-demethoxydaunokrubicin (IDA) in the treatment of acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lü JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):750-2. PubMed ID: 16483490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of antileukemic activity of rapamycin in elderly patients with acute myeloid leukemia evolving from a myelodysplastic syndrome.
    Callera F; Lopes CO; Rosa ES; Mulin CC
    Leuk Res; 2008 Oct; 32(10):1633-4. PubMed ID: 18405970
    [No Abstract]   [Full Text] [Related]  

  • 36. [Administration of antineoplastic agent of high molecular weight, neocarzinostatin, in cases of gastric cancer].
    Aneha Y; Kikuchi K; Kanno H
    Nihon Rinsho; 1974 Apr; 32(4):870-4. PubMed ID: 4858854
    [No Abstract]   [Full Text] [Related]  

  • 37. Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.
    Russo D; Piccaluga PP; Michieli M; Michelutti T; Visani G; Gugliotta L; Bonini A; Pierri I; Gobbi M; Tiribelli M; Fanin R; Piccolrovazzi S; Baccarani M
    Ann Hematol; 2002 Aug; 81(8):462-6. PubMed ID: 12224004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute leukemia: early recognition can spell survival.
    Vaughan WP; Karp JE; Burke PJ
    Geriatrics; 1981 Jun; 36(6):32-6. PubMed ID: 6939652
    [No Abstract]   [Full Text] [Related]  

  • 39. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
    Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
    Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Can the toxicity of rubidomycin in the treatment of acute leukemia in children be limited?].
    Wyszkowski J; Cyklis R; Armata J; Zajaczkowski J
    Przegl Lek; 1971; 27(4):335-8. PubMed ID: 5283077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.